Unlock instant, AI-driven research and patent intelligence for your innovation.

Compositions for inducing immune responses specific to globo h and ssea3 and uses thereof in cancer treatment

a technology of immune response and globo h, which is applied in the field of compositions for inducing immune responses specific to globo h and ssea3 and their use in cancer treatment, can solve the problems of unsatisfactory anti-cancer efficacy, and achieve the effect of promoting the production of anti-globo h

Inactive Publication Date: 2009-12-24
ACAD SINIC
View PDF9 Cites 31 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0003]The present invention is based on an unexpected discoveries that (1) SSEA3, the immediate precursor of Globo H, is expressed at a high level in breast cancer stem cells and therefore can serve as a suitable target for breast cancer treatment, and (2) α-galactosyl-ceramide (α-GalCer) is an effective adjuvant that promotes production of anti-Globo H and anti-SSEA3 antibodies.
[0004]Accordingly, one aspect of this invention features an immune composition containing Globo H or its fragment (e.g., SSEA3) and an adjuvant (e.g., α-GalCer). Globo H or its fragment can be conjugated with Keyhole Limpet Hemocyanin (KLH). When administered into a subject (e.g., a human), this immune composition elicits immune responses (e.g., antibody production) targeting Globo H or its fragment and, therefore, is effective in treating cancer (e.g., breast cancer, prostate cancer, ovarian cancer, and lung cancer).

Problems solved by technology

While vaccines have been developed to elicit antibody responses against Globo H, their anti-cancer efficacies are unsatisfactory due to low antigenicity of Globo H. There is a need for a new vaccine capable of eliciting high levels of immune responses targeting Globo H.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions for inducing immune responses specific to globo h and ssea3 and uses thereof in cancer treatment
  • Compositions for inducing immune responses specific to globo h and ssea3 and uses thereof in cancer treatment
  • Compositions for inducing immune responses specific to globo h and ssea3 and uses thereof in cancer treatment

Examples

Experimental program
Comparison scheme
Effect test

example 1

Induction of Antibodies Specific to Globo H and SSEA3 with KLH-Conjugated Globo H and α-GalCer

[0034]Globo H-KLH was purchased from Optimer Pharmaceuticals. Three groups of 6-week-old female BALB / b mice (BioLASCO), two in each group, were injected (s.c.) with PBS (“control mice”), 0.6 μg KLH-Globo H (“Globo H mice”), and 0.6 μg KLH-Globo H in combination with 2 μg α-GalCer (“Globo H-GalCer mice”), respectively, once every week for three weeks. Sera were collected from the mice of each group 10 days after the last injection and antibodies specific to Globo H and SSEA3 were detected following the method described in Huang et al., Proc, Natl. Acad. Sci. USA 103:15-20 (2006). Briefly, the sera were diluted 1:25 with 3% BSA / PBS buffer and 50 ml of each diluted serum were incubated with a slide, to which Globo H and SSEA3 were attached, in a humidifying chamber for 1 hour. The slide was washed three times with 0.05% PBS / Tween 20 (PBST) and subsequently incubated with 100 μl Cy5-conjugated ...

example 2

Inhibition of FUT1 and FUT2 Via RNA Interference Reduced Levels of Globo H

[0036]The levels of FUT1 and FUT2 mRNAs in three breast cancer cell lines, MCF-7, MB157, and T-47D, were determined by quantitative RT-PCR as follows. Total RNAs were extracted from these cancer cells and cDNAs were produced via reverse transcription using the RNAs as the template and oligo(dT) as the primer. Fifty nanograms of the cDNAs were subjected to RT-PCR using the following primers: L-fut1: CCTGCCAGACTCTGAGTTCC and AGGCTTAGCCAATGTCCAGA as well as L-fut2: GGGAGTTACCGGTGCAGATA and R-fut2: GTCCCAGTGCCTTTGATGTT. The RT-PCR reaction was carried out under the following conditions: 50° C. for 2 min, 95° C. for 10 min, followed by 40 cycles of 95° C. for 10 sec and 60° C. for 1 min, using an ABI Prism 7000 Sequence Detection System and the results thus obtained were analyzed using the ABI Prism 7000 SDS software (Applied Biosystems) to obtain a threshold cycle number (Ct value) for the mRNA levels of FUT1 and ...

example 3

Anti-Cancer Effects of SiFUT1 and SiFUT2 Inhibiting Cancer Cell Growth

[0041]Breast cancer cells MB157 and T-47D were seeded at 1×104 cells per well in a 96-well plate (Corning). They were then mixed with or without the virus particles described in Example 2 above that express siFUT1 or siFUT2 and centrifuged at 300 g for 5 min for spin infection. 24 hours later, alamar blue (AbD Serotec) was added to the cells at a final concentration of 1:10 dilution and the cells were then cultured at 37° C., 5% CO2 for 3 hr. Subsequently, the absorbance at 544 nm and 590 nm was measured with a SpectraMax M2 Reader. The cells were cultured under the same conditions with fresh medium and the absorbance at 544 nm and 590 nm was again measured at 48, 72, and 96 hr after the initial seeding process. Results obtained from this study show that both the MB157 and T-47D cells infected with the virus particles decreased their growth rate as compared with the non-infected cells. These data demonstrate that ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Compositionaaaaaaaaaa
Immunogenicityaaaaaaaaaa
Login to View More

Abstract

An immune composition containing Globo H or its fragment (e.g., SSEA3) and an adjuvant, e.g., α-GalCer, for eliciting immune responses against Globo H or its fragment and uses thereof in cancer treatment. Also disclosed is a method of treating cancer by inhibiting the activity of one of FUT1 and FUT2, both of which involve in Globo H biosynthesis.

Description

RELATED APPLICATION[0001]This application claims priority to U.S. Provisional Application No. 61 / 061,968, filed on Jun. 16, 2008, the content of which is hereby incorporated by reference in its entirety.BACKGROUND OF THE INVENTION[0002]Globo H is a cancer antigen overly expressed in various epithelial cancers. It has been suggested that this antigen can serve as a target in cancer immunotherapy. While vaccines have been developed to elicit antibody responses against Globo H, their anti-cancer efficacies are unsatisfactory due to low antigenicity of Globo H. There is a need for a new vaccine capable of eliciting high levels of immune responses targeting Globo H.SUMMARY OF THE INVENTION[0003]The present invention is based on an unexpected discoveries that (1) SSEA3, the immediate precursor of Globo H, is expressed at a high level in breast cancer stem cells and therefore can serve as a suitable target for breast cancer treatment, and (2) α-galactosyl-ceramide (α-GalCer) is an effectiv...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K39/00A61K31/7105A61P35/00
CPCA61K39/0011A61K2039/55511C12N2310/14C12N15/1137A61K2039/6081A61P35/00A61P35/04A61P43/00A61K39/001173A61K39/00118A61K31/716A61K31/164A61K31/7008A61K2039/6037A61K2039/627
Inventor WONG, CHI-HUEYYU, ALICE L.YU, JOHN.
Owner ACAD SINIC